BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 8813166)

  • 21. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
    Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension].
    Astrup LB; Solvig J; Cwikiel W
    Ugeskr Laeger; 1998 Mar; 160(11):1627-32. PubMed ID: 9522655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular intrahepatic portosystemic shunt in adult liver recipient with delayed graft function.
    Vasta F; Luca A; Miraglia R; Spada M; Gruttadauria S; Verzaro R; Cintorino D; Mandala L; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2005; 37(6):2626-8. PubMed ID: 16182767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension.
    Wu X; Ding W; Cao J; Fan X; Li J
    Am Surg; 2013 Mar; 79(3):305-12. PubMed ID: 23461959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of portal hypertension by portosystemic shunts].
    Rössle M; Siegerstetter V; Huber M
    Ther Umsch; 1998 Feb; 55(2):89-96. PubMed ID: 9545850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
    Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
    Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis.
    Silva RF; Arroyo PC; Duca WJ; Silva AA; Reis LF; Cabral CM; Sgnolf A; Domingues RB; Barao GT; Coelho DJ; Deberaldini M; Felício HC; Silva RC
    Transplant Proc; 2004 May; 36(4):926-8. PubMed ID: 15194319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease?
    Forster J; Siegel EL; Delcore R; Payne KM; Laurin J; Kindscher JD
    Am J Surg; 1996 Nov; 172(5):536-9; discussion 539-40. PubMed ID: 8942559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of elective operation in the treatment of portal hypertension.
    Becker YT; Reed G; Lind CD; Richards WO
    Am Surg; 1996 Mar; 62(3):171-7. PubMed ID: 8607573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results.
    Saad WE; Saad NE; Davies MG; Bozorgdadeh A; Orloff MS; Patel NC; Abt PL; Lee DE; Sahler LG; Kitanosono T; Sasson T; Waldman DL
    J Vasc Interv Radiol; 2006 Jun; 17(6):995-1002. PubMed ID: 16778233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.